-
The newer, more potent, statin drugs are capable of reducing LDL cholesterol safely and tolerably in most patients thus making a target LDL of 50-70 mg/dL a practical goal, but how low is too low?
-
An NIH Consensus Panel has announced new recommendations for the diagnosis of celiac disease using new serologic testing.
-
Peripheral arterial disease may be stratified in severity by the ankle-brachial index, measured by dividing the ankle systolic BP by the brachial systolic BP.
-
YKL-40 may represent a novel marker for the detection of early-stage ovarian cancer. YKL-40 levels in early stage patients may also predict disease recurrence and survival. The use of YKL-40 in detection of early stage ovarian cancer deserves further investigation.
-
Routine pelvic and para-aortic lymph node dissection is not necessary in the majority of women with ovarian low malignant potential tumors.
-
-
Viagra: Maximum Capacity at High-Altitudes?; FDA Actions.
-
Brinker F. Coming clean on supplements designated the 'Dirty Dozen.' Altern Med Alert 2004;7(10):109-119.
-
Greenfield R. Ginseng and warfarin. Altern Med Alert 2004;7(10):119-120.
-
Patient handout: Herbal supplements--Safety. Altern Med Alert 2004;7(10):S1-S2.